Therapeutic options for extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases producing Escherichia coli and Klebsiella sp. isolated from various clinical samples

Therapeutic options for extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases producing Escherichia coli and Klebsiella sp. isolated from various clinical samples

Escherichia coli and Klebsiella sp. are the predominant species isolated from clinical samples. Recent and proper understanding of the antibiotic susceptibility pattern of extended-spectrum β-lactamases (ESBL) and AmpC β-lactamases (AmpC) producing E. coli and Klebsiella sp. will prevent the distrib...

Full description

Bibliographic Details
Main Authors: Vimal Kumar, Narinder Kaur, Shubham Chauhan, Rosy Bala, Jyoti Chauhan, Harit Kumar, Shivani Devi
Format: Article
Language:English
Published: Universitas Gadjah Mada 2022-11-01
Series:Journal of the Medical Sciences
Subjects:
esbl
ampc
β-lactamase
producer
bacterial resistance
e. coli
klebsiella sp.
Online Access:https://jurnal.ugm.ac.id/bik/article/view/74026

Internet

https://jurnal.ugm.ac.id/bik/article/view/74026

Similar Items